Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Read more at CNBC
Topics
-
Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes
Top stories - NBC News - October 24 -
Ozempic lowers Alzheimer’s risk: Research
Politics - The Hill - October 24 -
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Business - CNBC - October 30 -
With Novo Nordisk success, is there a "Nokia risk" for Denmark?
Top stories - CBS News - November 3 -
The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research
Top stories - CBS News - November 4 -
Ozempic maker Novo Nordisk nudges higher profit forecast
Business - MarketWatch - November 6 -
Novo Nordisk's obesity-fighting drugs fatten Denmark's economy
Top stories - CBS News - November 3 -
Weight loss drug industry injects wealth into Novo Nordisk home country
Top stories - CBS News - November 3
More from CNBC
-
Target's recent trade imports data tells the real story behind massive earnings miss
Business - CNBC - 53 minutes ago -
Home sales surged in October, just before mortgage rates jumped
Business - CNBC - 35 minutes ago -
Bitcoin hits fresh record, races toward $100,000 as rally continues
Business - CNBC - 53 minutes ago -
Trump and Fed Chair Powell could be set on a collision course over interest rates
Business - CNBC - 1 hour ago -
Rep. Marjorie Taylor Greene tapped to work with Elon Musk and Vivek Ramaswamy as new DOGE subcommittee chair
Business - CNBC - 13 minutes ago